Get the Stockscreener App
1.79
3.76%
-0.07
After Hours:
1.81
0.02
+1.12%
Esperion Therapeutics Inc Stock (ESPR) Latest News
Esperion Therapeutics’ (ESPR) Market Outperform Rating Reaffirmed at JMP Securities - Defense World
Esperion Therapeutics' (ESPR) Buy Rating Reiterated at HC Wainwright - MarketBeat
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
ESPR Shares Experience Surge in Value - Knox Daily
SG Americas Securities LLC Increases Stock Position in Esperion Therapeutics, Inc. (NASDAQ:ESPR) - Defense World
What was Esperion Therapeutics Inc (ESPR)’s performance in the last session? - US Post News
Market Resilience: Esperion Therapeutics Inc (ESPR) Finishes Weak at 1.79, Down -1.10 - The Dwinnex
Esperion Therapeutics chief commercial officer sells $277 in stock - MSN
What is HC Wainwright’s Estimate for ESPR FY2028 Earnings? - Defense World
What is HC Wainwright's Estimate for ESPR FY2028 Earnings? - MarketBeat
Esperion Therapeutics’ (ESPR) Buy Rating Reiterated at HC Wainwright - Defense World
JMP Securities maintains $7 target on Esperion stock - MSN
JMP Securities maintains $7 target on Esperion stock By Investing.com - Investing.com Canada
Esperion Therapeutics' (ESPR) "Market Outperform" Rating Reiterated at JMP Securities - MarketBeat
HC Wainwright Reiterates Buy Rating for Esperion Therapeutics (NASDAQ:ESPR) - MarketBeat
Equities Analysts Set Expectations for ESPR FY2025 Earnings - MarketBeat
Cantor Fitzgerald Comments on ESPR FY2025 Earnings - Defense World
Esperion Therapeutics chief commercial officer sells $277 in stock By Investing.com - Investing.com Australia
Esperion Therapeutics CFO sells shares worth $20 By Investing.com - Investing.com South Africa
Esperion Therapeutics CFO sells shares worth $20 - Investing.com India
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Short Interest Update - MarketBeat
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Stock Position Lifted by Barclays PLC - Defense World
Barclays PLC Grows Position in Esperion Therapeutics, Inc. (NASDAQ:ESPR) - MarketBeat
Esperion stock falls on higher operating expense forecast - MSN
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives $7.30 Consensus Target Price from Analysts - Defense World
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
HC Wainwright Reiterates “Buy” Rating for Esperion Therapeutics (NASDAQ:ESPR) - Defense World
IMTX: 3 Small-Cap Healthcare Stocks With Big Upside Potential - StockNews.com
Esperion to Host Virtual Key Opinion Leader Event on Wednesday, January 22, 2025, at 11:30 a.m. ET. - The Manila Times
Esperion to Host KOL Event on NEXLETOL, NEXLIZET Real-World Impact in Cholesterol Management - StockTitan
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Call Transcript - MSN
Geode Capital Management LLC Acquires 171,609 Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) - Defense World
Best 5 Penny Stocks With Great Financial Health (February 2025) - Investing.com
Esperion to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference - The Bakersfield Californian
Esperion to Present at J.P. Morgan Healthcare Conference: Showcasing Non-Statin Breakthroughs - StockTitan
FINAL DEADLINE ALERT: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Immediately Contact the Firm - AccessWire
Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 16.5% - MarketBeat
ZTS: 3 Healthcare Innovators with Analyst-Endorsed Upside - StockNews.com
Public Employees Retirement System of Ohio Buys New Position in Esperion Therapeutics, Inc. (NASDAQ:ESPR) - MarketBeat
ESPREsperion Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Wellington Management Group LLP Grows Stock Holdings in Esperion Therapeutics, Inc. (NASDAQ:ESPR) - MarketBeat
2.34%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):